
Genexine
Clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics.
Market cap
$199m
Enterprise value
$249m
Share price
KRW5180.00 095700.KQ
Recent deals
Authorizing premium user...
Clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics.